NDA 050532

LILLY

FDA Drug Application

Application #050532

Application Sponsors

NDA 050532

LILLY

Marketing Status

• Discontinued: 001

Application Products

001

SOLUTION;TOPICAL

2%

0

ERYTHROMYCIN

ERYTHROMYCIN

FDA Submissions

TYPE 3; Type 3 - New Dosage Form	ORIG	1	AP	1980-06-03	STANDARD
LABELING; Labeling	SUPPL	5	AP	1990-12-07
LABELING; Labeling	SUPPL	6	AP	1990-12-07
LABELING; Labeling	SUPPL	9	AP	1980-11-14
LABELING; Labeling	SUPPL	10	AP	1981-06-03

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 50532
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)